184 related articles for article (PubMed ID: 29374627)
1. Morbidity and mortality with early pulmonary haemorrhage in preterm neonates.
Ahmad KA; Bennett MM; Ahmad SF; Clark RH; Tolia VN
Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F63-F68. PubMed ID: 29374627
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
3. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study.
Travers CP; Clark RH; Spitzer AR; Das A; Garite TJ; Carlo WA
BMJ; 2017 Mar; 356():j1039. PubMed ID: 28351838
[No Abstract] [Full Text] [Related]
4. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
[TBL] [Abstract][Full Text] [Related]
5. Antenatal care of mothers and morbidity and mortality disparities among preterm Saudi and non-Saudi infants less than or equal to 32 weeks' gestation.
Al-Mouqdad M; Abdelrahim A; Alodhaidan NA; Sumaily HH; Khalil TM; Asfour Y; Asfour SS
Ann Saudi Med; 2020; 40(4):290-297. PubMed ID: 32757992
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
Jeon GW; Oh M; Sin JB
Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
[TBL] [Abstract][Full Text] [Related]
7. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
[TBL] [Abstract][Full Text] [Related]
8. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort.
Manuck TA; Rice MM; Bailit JL; Grobman WA; Reddy UM; Wapner RJ; Thorp JM; Caritis SN; Prasad M; Tita AT; Saade GR; Sorokin Y; Rouse DJ; Blackwell SC; Tolosa JE;
Am J Obstet Gynecol; 2016 Jul; 215(1):103.e1-103.e14. PubMed ID: 26772790
[TBL] [Abstract][Full Text] [Related]
9. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study.
Ancel PY; Goffinet F; ; Kuhn P; Langer B; Matis J; Hernandorena X; Chabanier P; Joly-Pedespan L; Lecomte B; Vendittelli F; Dreyfus M; Guillois B; Burguet A; Sagot P; Sizun J; Beuchée A; Rouget F; Favreau A; Saliba E; Bednarek N; Morville P; Thiriez G; Marpeau L; Marret S; Kayem G; Durrmeyer X; Granier M; Baud O; Jarreau PH; Mitanchez D; Boileau P; Boulot P; Cambonie G; Daudé H; Bédu A; Mons F; Fresson J; Vieux R; Alberge C; Arnaud C; Vayssière C; Truffert P; Pierrat V; Subtil D; D'Ercole C; Gire C; Simeoni U; Bongain A; Sentilhes L; Rozé JC; Gondry J; Leke A; Deiber M; Claris O; Picaud JC; Ego A; Debillon T; Poulichet A; Coliné E; Favre A; Fléchelles O; Samperiz S; Ramful D; Branger B; Benhammou V; Foix-L'Hélias L; Marchand-Martin L; Kaminski M
JAMA Pediatr; 2015 Mar; 169(3):230-8. PubMed ID: 25621457
[TBL] [Abstract][Full Text] [Related]
10. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
Lamboley-Gilmert G; Lacaze-Masmonteil T;
Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
[TBL] [Abstract][Full Text] [Related]
11. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
12. Association of Early Inhaled Nitric Oxide With the Survival of Preterm Neonates With Pulmonary Hypoplasia.
Ellsworth KR; Ellsworth MA; Weaver AL; Mara KC; Clark RH; Carey WA
JAMA Pediatr; 2018 Jul; 172(7):e180761. PubMed ID: 29800952
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Preterm Infant Mortality and Severe Morbidity: A Population-Based Study.
Anderson JG; Rogers EE; Baer RJ; Oltman SP; Paynter R; Partridge JC; Rand L; Jelliffe-Pawlowski LL; Steurer MA
Neonatology; 2018; 113(1):44-54. PubMed ID: 29073624
[TBL] [Abstract][Full Text] [Related]
14. Surfactant Administration in Preterm Infants: Drug Development Opportunities.
Taylor G; Jackson W; Hornik CP; Koss A; Mantena S; Homsley K; Gattis B; Kudumu-Clavell M; Clark R; Smith PB; Laughon MM
J Pediatr; 2019 May; 208():163-168. PubMed ID: 30580975
[TBL] [Abstract][Full Text] [Related]
15. Lower mortality but higher neonatal morbidity over a decade in very preterm infants.
de Kleine MJ; den Ouden AL; Kollée LA; Ilsen A; van Wassenaer AG; Brand R; Verloove-Vanhorick SP
Paediatr Perinat Epidemiol; 2007 Jan; 21(1):15-25. PubMed ID: 17239175
[TBL] [Abstract][Full Text] [Related]
16. Actuarial Survival Based on Gestational Age in Days at Birth for Infants Born at <26 Weeks of Gestation.
Shah PS; Rau S; Yoon EW; Alvaro R; da Silva O; Makary H; Claveau M; Lee SK;
J Pediatr; 2020 Oct; 225():97-102.e3. PubMed ID: 32474028
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine growth restriction increases morbidity and mortality among premature neonates.
Garite TJ; Clark R; Thorp JA
Am J Obstet Gynecol; 2004 Aug; 191(2):481-7. PubMed ID: 15343225
[TBL] [Abstract][Full Text] [Related]
18. Early death, morbidity, and need of treatment among extremely premature infants.
Markestad T; Kaaresen PI; Rønnestad A; Reigstad H; Lossius K; Medbø S; Zanussi G; Engelund IE; Skjaerven R; Irgens LM;
Pediatrics; 2005 May; 115(5):1289-98. PubMed ID: 15867037
[TBL] [Abstract][Full Text] [Related]
19. Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial.
Lemyre B; Fusch C; Schmölzer GM; Rouvinez Bouali N; Reddy D; Barrowman N; Huneault-Purney N; Lacaze-Masmonteil T
PLoS One; 2017; 12(5):e0175922. PubMed ID: 28472058
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants.
Sharma P; McKay K; Rosenkrantz TS; Hussain N
BMC Pediatr; 2004 Jun; 4():9. PubMed ID: 15186501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
